ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MXF Medicx Fund

96.40
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medicx Fund LSE:MXF London Ordinary Share GG00B1DVQL92 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 96.40 95.80 96.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Medicx Share Discussion Threads

Showing 126 to 149 of 350 messages
Chat Pages: 14  13  12  11  10  9  8  7  6  5  4  3  Older
DateSubjectAuthorDiscuss
09/12/2015
16:36
First time they have admitted the dividend has partly come from capital. So any divi rise in the future is likely to be pretty small. But it will gradually become more sustainable as corrective action is taken. Plenty to like.
grahamg8
09/12/2015
11:00
Remains a steady earner ..minuscule increase in div forecast for next year but happy they are looking to increase divi cover further Hold
badtime
09/12/2015
08:05
Key achievements of 2015
Financial results
· 5.4 pence per share increase in EPRA NAV for the year to 70.8 pence per share (30 September 2014: 65.4 pence per share)
· Quarterly dividend of 1.475p per share announced in October 20154; total dividends of 5.9p per share for the year or 7.0% dividend yield (2014: total dividends of 5.8p per share; 6.9% dividend yield)4,5
· EPRA earnings of £13.4 million, an increase of £4.7 million or 54% from prior year, equivalent to 3.7p per share (30 September 2014: £8.7 million; 2.5p per share)6
· Dividend and underlying dividend cover 63.3% and 68.0% respectively (30 September 2014: 53.6% and 67.1%)7
· Discounted cash flow net asset value of £346.3 million equivalent to 94.9p per share (30 September 2014: £331.1 million; 93.4p per share)
· EPRA NNNAV of £228.9 million equivalent to 62.7p per share (30 September 2014: £229.2 million; 64.7p per share)6
Investments
· New committed and approved investments since 1 October 2014 of £41.2 million acquired at a cash yield of 5.78%1
· First investment made in the Republic of Ireland of €10.1 million
· £559.5 million committed investment in 148 primary healthcare properties as at 4 December 2015, an increase of 8.0% (8 December 2014): £518.2 million, 137 properties)1,8
· Annualised rent roll at 4 December 2015 of £35.8 million with 88.3% of rents reimbursed by the NHS, an increase of £3.0 million, or 9.1%, since 8 December 20141
· Strong pipeline of approximately £126.0 million of acquisition opportunities1
Funding
· Market capitalisation £308.5 million1 following share price appreciation and £6.9 million net proceeds raised from 8.3 million shares issued since 1 October 2014 at an average issue price of 83.1p per share1
· New £50 million loan note with an agreed term of thirteen years and five months with an all-in fixed rate of 3.838%
· The maturity on an existing £50 million loan note was extended nine years and three months to mature in December 2028
· Total drawn debt facilities of £338.3 million with an average all-in fixed rate cost of debt of 4.45% and an average unexpired term of 15.0 years, close to average unexpired lease term of the investment properties of 15.8 years and compared with 4.35% and 13.3 years for the prior year
· Net debt of £281.4 million equating to 50.2% adjusted gearing at 30 September 2015 (30 September 2014: £255.2 million; 49.9%)

more....

skinny
11/11/2015
13:11
Rath u must be pleased with your purchase ..ex div nxt week
badtime
24/10/2015
10:16
Acquisition of four modern primary healthcare centres

MedicX Fund Limited, (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, is pleased to announce that it has completed the acquisition of four operational and fully let primary healthcare properties. The transaction is consistent with the Fund's investment strategy of acquiring modern, purpose-built primary healthcare properties and with its objective of achieving rising rental income and capital growth.

The initial purchase price was £11.4 million with a further £0.6 million payable on completion of leases related to space being fitted out at one of the properties. A property at Fakenham was purchased by way of a corporate acquisition whereas the other three properties located in Wymondham, Abergele and Salisbury were property purchases.

The MedicX Fund's total property portfolio now comprises 147 properties throughout the United Kingdom and Ireland of which 141 are operational and fully let, with six under construction. The annualised rent roll for all properties is now £35.5 million.

- End -

skinny
28/9/2015
17:11
I was waiting for a drift lower so was pleasantly pleased to have picked up my first tranche today at 77.7p
rathkum
28/9/2015
11:41
One would hope for a bounce from here
badtime
28/7/2015
06:10
The Directors have approved a quarterly dividend of 1.475p per Ordinary Share in respect of the period 1 April 2015 to 30 June 2015. The Directors expect, subject to unforeseen circumstances, to pay dividends totalling 5.9p per Ordinary Share in respect of the financial year ending 30 September 2015. The dividend will be paid on 30 September 2015 to ordinary shareholders on the register as at 14 August 2015 (the "Record Date"). The corresponding ex-dividend date will be 13 August 2015.

The Company is offering qualifying shareholders the opportunity to take new ordinary shares in the Company, credited as fully paid, in lieu of the cash dividend to be paid on 30 September 2015, by participating in the Scrip Dividend Scheme (the "Scheme") previously put in place by the Company on 5 May 2010.

The option to participate will be available to shareholders until 9 September 2015 (the "election date"). Further information on the Scheme, together with a copy of the Scheme Document (which contains the terms and conditions of the Scheme) and relevant mandate form document, is available for inspection at the National Storage Mechanism ( or through the Scrip Dividend portal on the Company's website (

End

skinny
26/6/2015
07:55
MedicX Fund, (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, is pleased to announce that it has contracted to acquire, by way of forward funding, a new primary healthcare medical centre in Mullingar, Westmeath. The property is due to be completed in August 2016.

The completed development will be let to a number of GPs and the Health Service Executive (the Irish NHS equivalent). The GP and Health Service Executive leases will be for a term of 15 and 25 years respectively from practical completion. The rent is subject to five-yearly CPI reviews. The total acquisition cost of the property is €10.1 million.

This is the Company's first acquisition in Ireland, and has followed a significant due diligence exercise into the opportunities available in the Irish healthcare property market. It is the belief of Octopus Healthcare Adviser and the Board that Ireland offers good yields for quality properties, let on long leases, generating principally government backed income, making Irish healthcare property opportunities an attractive fit with MedicX Fund's investment objective. The yields available in Ireland are currently higher than are available for similar properties in the UK. It is anticipated that any investment in Ireland will be part funded through additional borrowings drawn in Euros, thereby providing a natural partial hedge against Euro currency movements.

The Company expects to acquire further healthcare properties in Ireland in the future. In the event that such investment opportunities become material in the context of the Company's property portfolio, shareholder approval will be sought to continue making such acquisitions through an amendment to the Company's investment policy setting out a limit as to how much may be invested outside the UK.

The MedicX Fund's total property portfolio comprises 143 properties throughout the United Kingdom and Ireland of which 134 are operational and fully let, with nine under construction. The annualised rent roll for all properties is £34.4 million.


- End -

skinny
08/6/2015
11:40
New Edison research note released today...

No surprises with interim results -

speedsgh
05/6/2015
06:09
MedicX Fund, (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, is pleased to announce that it has contracted to acquire, by way of forward funding, a new primary healthcare medical centre in Benllech, Anglesey. The property is due to be completed in May 2016.
The acquisition is being made under the framework agreement with General Practice Investment Corporation ("GPI") which was agreed in May 2013. GPI have a strong pipeline of projects with a number expected to be contracted in the coming year.

The completed development will be let to a GP practice and the Betsi Cadwaladr University Local Health Board. All leases will be for a term of 20 years from practical completion. The rent is subject to three-yearly effectively upwards only market rent reviews. The total acquisition cost of the property is £2.9 million.

The MedicX Fund's total property portfolio now comprises 142 properties throughout the United Kingdom of which 134 are operational and fully let, with eight under construction. The annualised rent roll for all properties is now £34.0 million.

skinny
29/5/2015
14:05
"You can not loose with this share." Not sure I'd go that far. Sounds like almost tempting fate! Agreed MXF is a fairly boring, unexciting hold (which is a positive imo) but I will be happier when one day the dividend is fully covered.
speedsgh
29/5/2015
13:21
The development of medical facilities in the UK seems certain to go on relentlessly. We are becoming a bunch of unfit neurotics bent on spending ever increasing amounts of money on the NHS.
You can not loose with this share.

selborne_edge
22/5/2015
10:21
bdtime

Indeed so, seemed like a fairly decent update.
I`m considering adding a few more

soi
22/5/2015
08:44
Gd to see dividend cover up...lets hope that continues...this stock has been a nice little income earner
badtime
22/5/2015
06:06
Highlights

Financial results
· Total shareholder return of 5.4% for the six month period, of which 1.8% is attributable to share price movements (2014: 8.8%, of which 5.2% is attributable to share price movements)1

· Quarterly dividend of 1.475p per share announced in April 20152; total dividends of 5.9p per share expected for the year or 7.1% dividend yield (2014: total dividends of 5.8p per share; 6.9% dividend yield)3,4

· Dividend cover increased to 67% for the six month period (31 March 2014: 48%)5

· Adjusted earnings of £7.0 million, an increase of £2.3 million or 48.9% from the prior corresponding period, equivalent to 2.0p per share (31 March 2014: £4.7 million; 1.4p per share)6

· Adjusted net asset value of £250.6 million equivalent to 68.8p per share (30 September 2014: £233.1 million; 65.8p per share)6

· Discounted cash flow net asset value of £340.6 million equivalent to 93.5p per share (30 September 2014: £331.1 million; 93.4p per share)

Investments
· New committed investments between 1 October 2014 and 31 March 2015 of £17.2 million

· £535.5 million committed investment in 141 primary healthcare properties, an increase of 3.3% over the period (30 September 2014: £518.3 million, 137 properties)3,7

· Annualised rent roll now £33.9 million with 90% of rents reimbursed by the NHS, an increase of £1.1 million, or 3.4%, since 1 October 20143

· Strong pipeline of approximately £100 million of further acquisition opportunities3

Funding
· Market capitalisation £301.5 million3 including £6.8 million net proceeds raised from 8.3 million shares issued since 1 October 2014 at an average issue price of 82.9p per share

· New £50 million loan note completed since the period end with an agreed term of thirteen and a half years and an all-in fixed rate of 3.838%

· Total drawn debt facilities at 31 March 2015 of £291.5 million with an average all-in fixed rate of debt of 4.52% and an average unexpired term of 14.2 years, close to the average unexpired lease term of the investment properties of 15.6 years and compared with 4.35% and 13.3 years at 30 September 2014

· Net debt of £265.6 million equating to 49.7% adjusted gearing at 31 March 2015

skinny
10/12/2014
13:59
So they raise cash and then pay it back to you because their dividend is only 50% covered and then say that is a real yield!!?? At some point this merry-go-round will stop and these will take a real beating back to about 65p, but it's gone on for years and might continue for some time to come.
goliard
10/12/2014
11:19
Results out..as u were
badtime
17/11/2014
13:26
MEDICX is the best share I hold and I add to it frequently. The yield is of course the main attraction and I am sure that it will continue to be so.
selborne_edge
13/11/2014
10:30
Ex div today ....i hold AGR who i rate higher...but these continue to provide a gd income ..glad i added on that dip
badtime
28/10/2014
12:23
Div confirmed 1.45p
badtime
16/10/2014
18:27
Bought a few to add toy existing holdings at 78
badtime
16/10/2014
11:33
Drifting into buying territory
badtime
04/10/2014
19:33
Yes, hold shares in this,PHP and Assura. Good sector. Odd though how Assura, which was the weakest is now the strongest of the three. I would rate Assura best, then PHP then MedicX but happy to hold all three.
topvest
Chat Pages: 14  13  12  11  10  9  8  7  6  5  4  3  Older

Your Recent History

Delayed Upgrade Clock